These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24020118)

  • 1. Tau pathology in diabetes mellitus.
    Wu J; Nie SD; Wang S
    Pharmazie; 2013 Aug; 68(8):649-52. PubMed ID: 24020118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research progress of abnormal phosphorylation of microtubule-associated tau protein and of the targeted inhibition of the phosphorylation].
    Zhou F; Chen S; Sun X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):788-92. PubMed ID: 23016437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Brain insulin signaling and Tau: impact for Alzheimer's disease and Tauopathies].
    Joly-Amado A; Gratuze M; Benderradji H; Vieau D; Buée L; Blum D
    Med Sci (Paris); 2018 Nov; 34(11):929-935. PubMed ID: 30526837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reinstated Activity of Human Tau-induced Enhanced Insulin Signaling Restricts Disease Pathogenesis by Regulating the Functioning of Kinases/Phosphatases and Tau Hyperphosphorylation in Drosophila.
    Pragati ; Sarkar S
    Mol Neurobiol; 2024 Feb; 61(2):982-1001. PubMed ID: 37674037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation differentiates tau-dependent neuronal toxicity and dysfunction.
    Papanikolopoulou K; Kosmidis S; Grammenoudi S; Skoulakis EM
    Biochem Soc Trans; 2010 Aug; 38(4):981-7. PubMed ID: 20658989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutual Relationship between Tau and Central Insulin Signalling: Consequences for AD and Tauopathies?
    Gratuze M; Joly-Amado A; Vieau D; Buée L; Blum D
    Neuroendocrinology; 2018; 107(2):181-195. PubMed ID: 29439247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two days of tau: a meeting focused on its biology and pathology.
    Skoulakis EM; Mudher A
    Biochem Soc Trans; 2010 Aug; 38(4):953-4. PubMed ID: 20658983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From tau phosphorylation to tau aggregation: what about neuronal death?
    Buée L; Troquier L; Burnouf S; Belarbi K; Van der Jeugd A; Ahmed T; Fernandez-Gomez F; Caillierez R; Grosjean ME; Begard S; Barbot B; Demeyer D; Obriot H; Brion I; Buée-Scherrer V; Maurage CA; Balschun D; D'hooge R; Hamdane M; Blum D; Sergeant N
    Biochem Soc Trans; 2010 Aug; 38(4):967-72. PubMed ID: 20658986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invited review: Neuropathology of tauopathies: principles and practice.
    Kovacs GG
    Neuropathol Appl Neurobiol; 2015 Feb; 41(1):3-23. PubMed ID: 25495175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The microtubule-associated protein tau in neurodegenerative diseases. Tauopathies].
    Sánchez MP; Alvarez-Tallada V; Avila J
    Rev Neurol; 2001 Jul 16-31; 33(2):169-77. PubMed ID: 11562878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity.
    Fatouros C; Pir GJ; Biernat J; Koushika SP; Mandelkow E; Mandelkow EM; Schmidt E; Baumeister R
    Hum Mol Genet; 2012 Aug; 21(16):3587-603. PubMed ID: 22611162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.
    Jiang T; Yu JT; Zhu XC; Zhang QQ; Cao L; Wang HF; Tan MS; Gao Q; Qin H; Zhang YD; Tan L
    Neuropharmacology; 2014 Oct; 85():121-30. PubMed ID: 24880087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau.
    Williams DR
    Intern Med J; 2006 Oct; 36(10):652-60. PubMed ID: 16958643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau protein phosphatases in Alzheimer's disease: the leading role of PP2A.
    Martin L; Latypova X; Wilson CM; Magnaudeix A; Perrin ML; Terro F
    Ageing Res Rev; 2013 Jan; 12(1):39-49. PubMed ID: 22771380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High cholesterol diet induces tau hyperphosphorylation in apolipoprotein E deficient mice.
    Rahman A; Akterin S; Flores-Morales A; Crisby M; Kivipelto M; Schultzberg M; Cedazo-Mínguez A
    FEBS Lett; 2005 Nov; 579(28):6411-6. PubMed ID: 16288750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare Tauopathies.
    Ali F; Josephs K
    Semin Neurol; 2019 Apr; 39(2):264-273. PubMed ID: 30925618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous nonsense mutation in SYNJ1 associated with intractable epilepsy and tau pathology.
    Dyment DA; Smith AC; Humphreys P; Schwartzentruber J; Beaulieu CL; ; Bulman DE; Majewski J; Woulfe J; Michaud J; Boycott KM
    Neurobiol Aging; 2015 Feb; 36(2):1222.e1-5. PubMed ID: 25316601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau oligomers as potential targets for early diagnosis of tauopathy.
    Sahara N; Ren Y; Ward S; Binder LI; Suhara T; Higuchi M
    J Alzheimers Dis; 2014; 40 Suppl 1():S91-6. PubMed ID: 24595194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuropathological spectrum of neurodegenerative tauopathies.
    Tolnay M; Probst A
    IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.